These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1463527)

  • 1. Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia.
    Müller O; Wettich K
    Infection; 1992; 20(3):176-82. PubMed ID: 1463527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL; Jacobson K; Guerra FJ
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of loracarbef in the treatment of pneumonia.
    Hyslop DL
    Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
    Foshee WS
    J Pediatr; 1992 Jun; 120(6):980-6. PubMed ID: 1593361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J; Ruoff GE; Jacobson KD
    Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.
    Gan VN; Kusmiesz H; Shelton S; Nelson JD
    Antimicrob Agents Chemother; 1991 May; 35(5):967-71. PubMed ID: 1854178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL; Bischoff W
    Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis.
    Müller O; Spirer Z; Wettich K
    Infection; 1992; 20(5):301-8. PubMed ID: 1428189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
    Zeckel ML
    Am J Med; 1992 Jun; 92(6A):58S-64S. PubMed ID: 1621746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
    McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
    Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; McTavish D
    Drugs; 1993 May; 45(5):716-36. PubMed ID: 7686466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.
    Floor M; van Akkeren F; Rozenberg-Arska M; Visser M; Kolsters A; Beumer H; Verhoef J
    Scand J Infect Dis; 1994; 26(2):191-7. PubMed ID: 8036475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. Scandinavian Study Group.
    J Antimicrob Chemother; 1993 Jun; 31(6):949-61. PubMed ID: 8360132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative United States and European trials of loracarbef in the treatment of acute otitis media.
    Foshee WS; Qvarnberg Y
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S12-9. PubMed ID: 1513607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population.
    McCarty J
    Am J Med; 1992 Jun; 92(6A):74S-79S. PubMed ID: 1621750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials.
    Nielsen RW
    Am J Med; 1992 Jun; 92(6A):70S-73S. PubMed ID: 1621749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.